Cytarabine
In Stock•Starting at $7 for 1 g•Purity ≥ 95%
| CAS No. | 147-94-4 |
|---|---|
| MDL No. | MFCD00066487 |
| MF | C9H13N3O5 |
| MW | 243.22 |
| InChI Key | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 g | 95%+ | $7 | In Stock | |
| 5 g | 95%+ | $9 | In Stock | |
| 10 g | 95% | $16 | In Stock | |
| 25 g | 95%+ | $30 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Cytarabine is a pyrimidine nucleoside in which cytosine is linked to D-arabinofuranose via a beta-N(1)-glycosidic bond. It is primarily used in the treatment of leukemia, particularly acute non-lymphoblastic leukemia. As an antimetabolite antineoplastic agent, it inhibits DNA synthesis. It also exhibits antiviral and immunosuppressant properties. Cytarabine functions as an antineoplastic, antimetabolite, antiviral, and immunosuppressive agent. It is a beta-D-arabinoside, a pyrimidine nucleoside, and a monosaccharide derivative, and is functionally related to cytosine.
| CAS No. | 147-94-4 |
|---|---|
| Product Name | Cytarabine |
Biological Targets
POLA1·POLD4·POLD3·POLD1·POLD2·
Associated Conditions
hematopoietic and lymphoid cell neoplasm·T-lymphoblastic lymphoma·chronic myelogenous leukemia·Burkitts lymphoma·chronic myelomonocytic leukemia·
* The information provided here is compiled from public sources and is for reference only.
